Skip to main content

Table 5 Univariate analysis in 1602 patients with invasive cancer

From: Reasons of not having breast reconstruction: a historical cohort of 1937 breast cancer patients undergoing mastectomy

 

Nonreconstructed N = 1200

Reconstructed N = 402

P-value

Age (years) - median (range)

59.6 (28–97)

50.5 (25–76)

< 0.001

Marital status - N (%)

  

0.171

Not partnered

266 (41.1)

77 (35.5)

 

Partnered

382 (59)

140 (64.5)

 

Employment status - N (%)

  

< 0.001

Not working outside home

457 (49.4)

67 (21.9)

 

Working outside home

469 (50.6)

239 (78.1)

 

BMIa (kg/m2) - N (%)

  

< 0.001

<20

158 (13.6)

69 (17.5)

 

20-25

527 (45.3)

216 (54.8)

 

26-30

317 (27.3)

72 (18.3)

 

>30

160 (13.8)

37 (9.4)

 

Tobacco users - N (%)

159 (13.3)

84 (20.9)

< 0.001

ASAb score - N (%)

  

< 0.001

ASA 1

557 (46.5)

272 (67.7)

 

ASA 2

588 (49)

128 (31.8)

 

ASA >2

54 (4.5)

2 (0.05)

 

Tumor size (cm) - N (%)

  

0.004

<2

377 (32)

156 (40.9)

 

2-5

619 (52.6)

167 (43.8)

 

>5

181 (15.4)

58 (15.2)

 

Axillary lymph nodes positive N (%) Median (range)

579 (48.3%) 1 (0–28)

147 (36.5) 0 (0–19)

< 0.001

Metastatic cancer - N (%)

76 (6.4)

9 (2.2)

0.002

Indication of mastectomy - N (%)

  

< 0.001

Clinicobiological characteristics of cancer

720 (60.1)

187 (46.5)

 

Failure conservative surgery

162 (13.5)

78 (19.4)

 

Local recurrence

317 (26.4)

137 (34.1)

 

Chemotherapy - N (%)

  

0.253

Adjuvant

501 (41.8)

187 (46.5)

 

Neoadjuvant

208 (17.3)

64 (15.9)

 

Radiotherapy - N (%)

720 (60)

212 (52.7)

0.012

Hormone therapy - N (%)

853 (71.1)

283 (70.4)

0.825

  1. aBMI body mass index.
  2. bASA American Society of Anesthesiologists.